NYSE American - Nasdaq Real Time Price USD
IGC Pharma, Inc. (IGC)
0.3184
+0.0009
+(0.29%)
As of 11:51:52 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BRADBURY STRATEGIC INVESTMENT FUND A Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Mar 22, 2024 | 13,823,500 |
| GRIMALDI CLAUDIA Director | Conversion of Exercise of derivative security | Mar 31, 2025 | 1,184,250 |
| MORAN JAMES P Director | Conversion of Exercise of derivative security | Mar 31, 2025 | 1,105,740 |
| MUKUNDA RAM Chief Executive Officer | Conversion of Exercise of derivative security | Mar 31, 2025 | 4,092,680 |
| PRINS RICHARD K Director | Conversion of Exercise of derivative security | Mar 31, 2025 | 1,271,250 |
Related Tickers
LIXT Lixte Biotechnology Holdings, Inc.
1.4533
+3.07%
TENX Tenax Therapeutics, Inc.
6.04
-0.74%
TSBX Turnstone Biologics Corp.
0.3308
+5.78%
DRMA Dermata Therapeutics, Inc.
0.7199
+2.86%
SLRX Salarius Pharmaceuticals, Inc.
0.7610
-2.80%
INTS Intensity Therapeutics, Inc.
0.5244
-11.27%
INDP Indaptus Therapeutics, Inc.
0.3569
+4.85%
RADX Radiopharm Theranostics Limited
5.27
+1.95%
ATHA Athira Pharma, Inc.
0.3147
+10.38%
SPRC SciSparc Ltd.
0.3132
-0.93%